Ferroptosis as a promising therapeutic strategy for melanoma
Frontiers in Pharmacology · 19.09.2023 · 14
DOI: 10.3389/fphar.2023.1252567 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.09.2023. Verfasst von Na Ta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Hospital of Chifeng University, Chifeng, China. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Malignant melanoma (MM) is the most common and deadliest type of skin cancer and is associated with high mortality rates across all races and ethnicities. Although present treatment options combined with surgery provide short-term clinical benefit in patients and early diagnosis of non-metastatic MM significantly increases the probability of survival, no efficacious treatments are available for MM. The etiology and pathogenesis of MM are complex. Acquired drug resistance is associated with a pool prognosis in patients with advanced-stage MM. Thus, these patients require new therapeutic strategies to improve their treatment response and prognosis. Multiple studies have revealed that ferroptosis, a non-apoptotic form of regulated cell death (RCD) characterized by iron dependant lipid peroxidation, can prevent the development of MM. Recent studies have indicated that targeting ferroptosis is a promising treatment strategy for MM. This review article summarizes the core mechanisms underlying the development of ferroptosis in MM cells and its potential role as a therapeutic target in MM. We emphasize the emerging types of small molecules inducing ferroptosis pathways by boosting the antitumor activity of BRAFi and immunotherapy and uncover their beneficial effects to treat MM. We also summarize the application of nanosensitizer-mediated unique dynamic therapeutic strategies and ferroptosis-based nanodrug targeting strategies as therapeutic options for MM. This review suggests that pharmacological induction of ferroptosis may be a potential therapeutic target for MM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, The Affiliated Hospital of Chifeng University, Chifeng, China.
- Department of Anatomy, College of Basic Medicine, Chifeng University Health Science Center, Chifeng, China.
- Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Chifeng University, Chifeng, China.
- Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute…
Zitieren
APA
Ta, N., Jiang, X., Zhang, Y., & Wang, H. (2023). Ferroptosis as a promising therapeutic strategy for melanoma. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1252567
Vancouver
Ta N, Jiang X, Zhang Y, Wang H. Ferroptosis as a promising therapeutic strategy for melanoma. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1252567
BibTeX
@article{Ta2023,
author = {Ta, Na and Jiang, Xiaodong and Zhang, Yongchun and Wang, Hongquan},
title = {Ferroptosis as a promising therapeutic strategy for melanoma},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1252567}
}
EUVIMED